The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Lemaitre Vascular Inc (NASDAQ: LMAT) closed at $95.28 in the last session, down -2.38% from day before closing price of $97.6. In other words, the price has decreased by -$2.38 from its previous closing price. On the day, 0.51 million shares were traded. LMAT stock price reached its highest trading level at $97.73 during the session, while it also had its lowest trading level at $89.25.
Ratios:
We take a closer look at LMAT’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.23. For the most recent quarter (mrq), Quick Ratio is recorded 11.74 and its Current Ratio is at 13.60. In the meantime, Its Debt-to-Equity ratio is 0.51 whereas as Long-Term Debt/Eq ratio is at 0.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 12 ’25 when Jasinski Lawrence J sold 976 shares for $92.78 per share. The transaction valued at 90,553 led to the insider holds 4,773 shares of the business.
Roberts David B sold 10,815 shares of LMAT for $999,173 on Aug 11 ’25. The President and Director now owns 17,976 shares after completing the transaction at $92.39 per share. On Aug 08 ’25, another insider, Ross Bridget A, who serves as the Director of the company, sold 2,500 shares for $94.00 each. As a result, the insider received 235,000 and left with 2,916 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LMAT now has a Market Capitalization of 2156900864 and an Enterprise Value of 2023304064. As of this moment, Lemaitre’s Price-to-Earnings (P/E) ratio for their current fiscal year is 46.27, and their Forward P/E ratio for the next fiscal year is 38.34. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.42. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.19 while its Price-to-Book (P/B) ratio in mrq is 5.95. Its current Enterprise Value per Revenue stands at 8.623 whereas that against EBITDA is 31.188.
Stock Price History:
The Beta on a monthly basis for LMAT is 0.78, which has changed by 0.07008088 over the last 52 weeks, in comparison to a change of 0.15624678 over the same period for the S&P500. Over the past 52 weeks, LMAT has reached a high of $109.58, while it has fallen to a 52-week low of $71.42. The 50-Day Moving Average of the stock is 10.13%, while the 200-Day Moving Average is calculated to be 5.49%.
Shares Statistics:
According to the various share statistics, LMAT traded on average about 159.33K shares per day over the past 3-months and 227290 shares per day over the past 10 days. A total of 22.64M shares are outstanding, with a floating share count of 20.79M. Insiders hold about 8.18% of the company’s shares, while institutions hold 94.02% stake in the company. Shares short for LMAT as of 1755216000 were 1259933 with a Short Ratio of 8.35, compared to 1752537600 on 1375142. Therefore, it implies a Short% of Shares Outstanding of 1259933 and a Short% of Float of 7.53.
Dividends & Splits
The forward annual dividend rate for LMAT is 0.76, which was 0.72 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.0073770494The stock’s 5-year Average Dividend Yield is 0.89.
Earnings Estimates
Currently, 9.0 analysts are dedicated to thoroughly evaluating and rating the performance of Lemaitre Vascular Inc (LMAT) in the stock market.The consensus estimate for the next quarter is $0.63, with high estimates of $0.65 and low estimates of $0.6.
Analysts are recommending an EPS of between $2.31 and $2.23 for the fiscal current year, implying an average EPS of $2.28. EPS for the following year is $2.49, with 10.0 analysts recommending between $2.6 and $2.35.
Revenue Estimates
According to 11 analysts, the current quarter’s revenue is expected to be $62.23M. It ranges from a high estimate of $62.77M to a low estimate of $61.2M. As of the current estimate, Lemaitre Vascular Inc’s year-ago sales were $54.82MFor the next quarter, 11 analysts are estimating revenue of $64.38M. There is a high estimate of $66.3M for the next quarter, whereas the lowest estimate is $62.7M.
A total of 11 analysts have provided revenue estimates for LMAT’s current fiscal year. The highest revenue estimate was $252.6M, while the lowest revenue estimate was $248M, resulting in an average revenue estimate of $250.72M. In the same quarter a year ago, actual revenue was $219.86MBased on 11 analysts’ estimates, the company’s revenue will be $272.35M in the next fiscal year. The high estimate is $282M and the low estimate is $256M.
